Zammit C, Nadel C, Nadel C, Lin Y, Koirala S, Potts P
bioRxiv. 2025; .
PMID: 39990458
PMC: 11844536.
DOI: 10.1101/2025.02.12.637117.
London N
Chem Rev. 2024; 125(1):326-368.
PMID: 39692621
PMC: 11719315.
DOI: 10.1021/acs.chemrev.4c00570.
Lawer A, Schulz L, Sawyer R, Liu X
Cells. 2024; 13(5.
PMID: 38474390
PMC: 10930881.
DOI: 10.3390/cells13050426.
Li J, Chen X, Lu A, Liang C
Innovation (Camb). 2023; 4(3):100413.
PMID: 37033156
PMC: 10074253.
DOI: 10.1016/j.xinn.2023.100413.
Heitel P
Molecules. 2023; 28(2).
PMID: 36677746
PMC: 9867477.
DOI: 10.3390/molecules28020690.
Targeted Protein Degradation: Clinical Advances in the Field of Oncology.
Salama A, Trkulja M, Casanova E, Uras I
Int J Mol Sci. 2022; 23(23).
PMID: 36499765
PMC: 9741350.
DOI: 10.3390/ijms232315440.
Design, Synthesis and Biological Characterization of Histone Deacetylase 8 (HDAC8) Proteolysis Targeting Chimeras (PROTACs) with Anti-Neuroblastoma Activity.
Darwish S, Ghazy E, Heimburg T, Herp D, Zeyen P, Salem-Altintas R
Int J Mol Sci. 2022; 23(14).
PMID: 35886887
PMC: 9322761.
DOI: 10.3390/ijms23147535.
Spirocyclic dimer SpiD7 activates the unfolded protein response to selectively inhibit growth and induce apoptosis of cancer cells.
Kour S, Rana S, Kubica S, Kizhake S, Ahmad M, Munoz-Trujillo C
J Biol Chem. 2022; 298(5):101890.
PMID: 35378132
PMC: 9062249.
DOI: 10.1016/j.jbc.2022.101890.
Direct targeting of TDP-43, from small molecules to biologics: the therapeutic landscape.
Francois-Moutal L, Scott D, Khanna M
RSC Chem Biol. 2021; 2(4):1158-1166.
PMID: 34458829
PMC: 8341936.
DOI: 10.1039/d1cb00110h.
The mRNA-Binding Protein HuR Is a Kinetically-Privileged Electrophile Sensor.
Poganik J, Van Hall-Beauvais A, Long M, Disare M, Zhao Y, Aye Y
Helv Chim Acta. 2021; 103(5).
PMID: 34113045
PMC: 8188987.
DOI: 10.1002/hlca.202000041.
Synthesis and evaluation of bifunctional PTP4A3 phosphatase inhibitors activating the ER stress pathway.
Rastelli E, Sannino S, Hart D, Sharlow E, Lazo J, Brodsky J
Bioorg Med Chem Lett. 2021; 46:128167.
PMID: 34089839
PMC: 8876255.
DOI: 10.1016/j.bmcl.2021.128167.
PROTACs to address the challenges facing small molecule inhibitors.
Martin-Acosta P, Xiao X
Eur J Med Chem. 2020; 210:112993.
PMID: 33189436
PMC: 7779748.
DOI: 10.1016/j.ejmech.2020.112993.
Bardoxolone conjugation enables targeted protein degradation of BRD4.
Tong B, Luo M, Xie Y, Spradlin J, Tallarico J, McKenna J
Sci Rep. 2020; 10(1):15543.
PMID: 32968148
PMC: 7511954.
DOI: 10.1038/s41598-020-72491-9.
A super-sensitive auxin-inducible degron system with an engineered auxin-TIR1 pair.
Nishimura K, Yamada R, Hagihara S, Iwasaki R, Uchida N, Kamura T
Nucleic Acids Res. 2020; 48(18):e108.
PMID: 32941625
PMC: 7544234.
DOI: 10.1093/nar/gkaa748.
Systematic Investigation of the Permeability of Androgen Receptor PROTACs.
Scott D, Rooney T, Bayle E, Mirza T, Willems H, Clarke J
ACS Med Chem Lett. 2020; 11(8):1539-1547.
PMID: 32832021
PMC: 7429968.
DOI: 10.1021/acsmedchemlett.0c00194.
Emerging New Concepts of Degrader Technologies.
Ding Y, Fei Y, Lu B
Trends Pharmacol Sci. 2020; 41(7):464-474.
PMID: 32416934
PMC: 7177145.
DOI: 10.1016/j.tips.2020.04.005.
Degradation of proteins by PROTACs and other strategies.
Wang Y, Jiang X, Feng F, Liu W, Sun H
Acta Pharm Sin B. 2020; 10(2):207-238.
PMID: 32082969
PMC: 7016280.
DOI: 10.1016/j.apsb.2019.08.001.
Modulation of chimeric antigen receptor surface expression by a small molecule switch.
Juillerat A, Tkach D, Busser B, Temburni S, Valton J, Duclert A
BMC Biotechnol. 2019; 19(1):44.
PMID: 31269942
PMC: 6610870.
DOI: 10.1186/s12896-019-0537-3.
Protein folding state-dependent sorting at the Golgi apparatus.
Hellerschmied D, Serebrenik Y, Shao L, Burslem G, Crews C
Mol Biol Cell. 2019; 30(17):2296-2308.
PMID: 31166830
PMC: 6743468.
DOI: 10.1091/mbc.E19-01-0069.
Targeted protein unfolding uncovers a Golgi-specific transcriptional stress response.
Serebrenik Y, Hellerschmied D, Toure M, Lopez-Giraldez F, Brookner D, Crews C
Mol Biol Cell. 2018; 29(11):1284-1298.
PMID: 29851555
PMC: 5994893.
DOI: 10.1091/mbc.E17-11-0693.